Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia

Movement Disorders

Volumn 20, Issue 8, 2005, Pages 999-1005

  Osaki, Yasushi ^a   Morita, Yukari ^a   Fukumoto, Mitsutaka ^a   Akagi, Naoki ^a   Yoshida, Shoji ^a   Doi, Yoshinori ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

3D SSP SPECT; Dementia; Parkinson's disease

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE COURSE; FEMALE; FRONTAL LOBE; HUMAN; MALE; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VISUAL CORTEX; VISUAL HALLUCINATION;

AGED; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PARKINSON DISEASE; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 26444455073     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20463     Document Type: Article

References (23)

1. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:308-312.
2. Mindham RHS. The place of dementia in Parkinson's disease: a methodologic saga. Adv Neurol 1999;80:403-408.
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
4. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001;56:730-736.
5. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
6. McKeith I, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28.
7. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
8. Mizumura S, Kumita S, Ishihara M, et al. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 2003;17:289-295.
9. 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001; 42:548-557.
10. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
11. Byrne EJ, Lennox G, Lowe G, et al. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989; 52:709-717.
12. Fahn S, Elton RL. Members of the Unified Parkinson's Disease Rating Scale Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent development in Parkinson's disease. New York: Macmillan; 1987. p 153-163.
13. Minoshima S, Frey KA, Koeppe RA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.
14. Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and compromised cerebral blood flow reactivity. J Neurosurg 1993;79:483-489.
15. m-Tc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1991;54:787-792.
16. Sawada H, Udaka F, Kameyama M, et al. SPECT finding in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 1992;55:960-963.
17. Antonini A, De Notaris R, Benti R, Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 2001;22:45-46.
18. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003;20:1309-1319.
19. Abe Y, Kachi T, Arahata Y, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-422.
20. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
21. Camicioli RM, Korzan JR, Foster SL, et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 2004;354:177-180.
22. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125:391-400.
23. Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 2002;125:2431-2445.